3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients
- PMID: 1813066
- DOI: 10.1007/BF01833353
3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients
Abstract
Breast cancers from 476 elderly patients, 70 years and older, operated on since 1972, were analyzed for proliferative activity, hormone receptors, and DNA content. Tumor proliferative activity, expressed as 3H-thymidine labeling index (3H-TdR LI), had a median value of 3.4%, which progressively increased from 1972 to 1990. Estrogen and progesterone receptors were present respectively in 83% and 61% of the cases; the positivity for estrogen receptors slightly increased with time. Aneuploid clones were detected in 74% of the cases, and this incidence was relatively stable during the time of observation. 3H-TdR LI, hormone receptors, and ploidy were generally unrelated to the local-regional extension of the disease in these elderly patients, in agreement with observations on cancer from younger patients. However, the absence of hormone receptors and the presence of aneuploidy were markedly indicative of fast cell proliferation. As in younger patients, these biologic findings in elderly patients could be considered as a complement to clinico-pathologic features in a 'risk-factor profile system' for treatment planning.
Similar articles
-
Biological correlation between HER-2/neu and proliferative activity in human breast cancer.Anticancer Res. 1991 Jul-Aug;11(4):1395-400. Anticancer Res. 1991. PMID: 1684096
-
DNA ploidy of human breast cancer.Anal Cell Pathol. 1989 Aug;1(4):215-23. Anal Cell Pathol. 1989. PMID: 2487046
-
Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.Acta Oncol. 1992;31(3):283-92. doi: 10.3109/02841869209108174. Acta Oncol. 1992. PMID: 1622647
-
New biologic prognostic factors in breast cancer.Oncology (Williston Park). 1989 May;3(5):49-54; discussion 58, 61, 64. Oncology (Williston Park). 1989. PMID: 2578003 Review.
-
HER2 as a prognostic factor in breast cancer.Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
Cited by
-
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women.Br J Cancer. 2000 Jan;82(2):270-7. doi: 10.1054/bjoc.1999.0914. Br J Cancer. 2000. PMID: 10646876 Free PMC article.
-
Breast cancer in the elderly.Postgrad Med J. 1995 Nov;71(841):658-64. doi: 10.1136/pgmj.71.841.658. Postgrad Med J. 1995. PMID: 7494769 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials